Related Experiment Video
Updated: Jul 19, 2026

Subcutaneous Angiotensin II Infusion using Osmotic Pumps Induces Aortic Aneurysms in Mice
Published on: September 28, 2015
Polymorphisms in the angiotensin converting enzyme gene and growth in the first year of life
P C Hindmarsh1, C H Rodeck, S E Humphries
1Centre for Human Growth and Maturation, Institute of Child Health, London, UK. p.hindmarsh@ucl.ac.uk
Insights
The angiotensin converting enzyme (ACE) I/I genotype is linked to increased weight and body mass index in infants, showing catch-up growth. The ACE D/D genotype is associated with a higher proportion of small-for-gestational-age infants.
Area of Science:
- Genetics
- Pediatrics
- Cardiovascular Disease Risk
Background:
- Abnormal fetal and infant growth patterns are linked to adult cardiovascular disease.
- Catch-up growth in infancy is associated with type 2 diabetes, while lack of it is linked to hypertension.
- The influence of genetic factors on early growth and blood pressure requires further investigation.
Purpose of the Study:
- To investigate the association between angiotensin converting enzyme (ACE) gene polymorphisms and early human growth patterns.
- To explore the role of ACE genotype in infant size at birth and at one year of age.
- To determine if ACE genotype influences catch-up growth in infancy.
Main Methods:
- Genotyping of the ACE gene (I/D alleles) in cord blood samples from 530 Caucasian infants.
- Measurement of infant size at birth and at one year of age.
- Statistical analysis including regression models to assess genotype-phenotype associations.
Main Results:
- The ACE I/I genotype was significantly associated with higher weight, body mass index, and mid-arm circumference at one year.
- Infants with the I/I genotype showed significant catch-up growth in weight, body mass index, and mid-arm circumference compared to the D/D group.
- The ACE D/D genotype was associated with a greater proportion of infants born small for gestational age.
Conclusions:
- The ACE I/I genotype is linked to accelerated postnatal growth and higher body mass index in the first year of life.
- The ACE D/D genotype is associated with a higher incidence of being small for gestational age.
- Genotype, sex, and socioeconomic status independently influence infant growth, highlighting the need for integrated causality models.
Abstract:
Abnormal patterns of fetal and infant growth have been associated with an increased risk of cardiovascular disease in adulthood. Catch-up growth during the first year of life has been associated with a higher prevalence of type 2 diabetes mellitus, whereas a lack of catch-up growth tracks with a risk of hypertension. The role of genetic factors influencing both growth and blood pressure have not been explored. We genotyped cord blood samples from 530 singleton, Caucasian, uncomplicated pregnancies, drawn from a larger cohort of 1650 pregnancies, and related polymorphism in the angiotensin converting enzyme (ACE) gene (alleles insertion (I) or deletion (D)) with measures of size at birth and at age of 1 year. ACE genotype did not significantly influence size at birth, although there was a greater proportion of individuals with the D/D genotype born with a birth weight less than the 10th centile (P=0.004). The ACE I/I genotype was significantly associated with higher weight (p=0.001), body mass index (p=0.001) and mid arm circumference (p=0.001) at 1 year of age compared to the ACE D/D and I/D genotypes. Individuals with the I/I genotype displayed catch-up (gain from birth size of >or=0.6 Standard Deviation Score) in weight (p=0.04), body mass index (p=0.03) and mid arm circumference (p=0.03) compared to the D/D group, the majority of which showed no change or catch-down. The I/D genotype was distributed equally across the catch up/catch down/no change categories. The effect was more marked in males, but ACE genotype and sex of the infant contributed independently to mid arm circumference measurements and there was no interaction between the two. There was no effect of maternal or paternal ACE genotype on birth size. In a multiple linear regression model ACE genotype, socioeconomic status and sex of the infant explained 10.9% of the variance in body mass index SDS at 1 year of age. We conclude that the ACE I/I genotype is associated with a higher weight and body mass index SDS at 1 year of age, along with catch-up in terms of these measures from birth to 1 year. The D/D genotype is associated with a greater proportion of babies, born at term, that at small for gestational age. These results suggest that due consideration should be given to the underlying genotype of an individual when evaluating the association of early human growth with the development of risk factors for cardiovascular disease. The observation of independent effects of genotype, sex of the individual and socioeconomic status on postnatal growth suggests the need to develop methodologies for the integration of genetic and environmental factors in causality modelling.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Hormonal Regulation
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Regulation of Angiogenesis and Blood Supply
